Cargando…
Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report
Thyroid storm (TS) is a rare and life-threatening medical emergency, most commonly caused by Graves’ disease (GD). GD can be induced by immune reconstitution therapy (IRT) such as alemtuzumab (ALZ), a humanized monoclonal antibody against CD52, which is shown to be effective in the treatment of rela...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138563/ https://www.ncbi.nlm.nih.gov/pubmed/35651398 http://dx.doi.org/10.7759/cureus.24570 |
_version_ | 1784714652933947392 |
---|---|
author | AlShehri, Sara Alajmi, Sarah Ekhzaimy, Aishah Aldawas, Sadeem Alalwan, Maryam |
author_facet | AlShehri, Sara Alajmi, Sarah Ekhzaimy, Aishah Aldawas, Sadeem Alalwan, Maryam |
author_sort | AlShehri, Sara |
collection | PubMed |
description | Thyroid storm (TS) is a rare and life-threatening medical emergency, most commonly caused by Graves’ disease (GD). GD can be induced by immune reconstitution therapy (IRT) such as alemtuzumab (ALZ), a humanized monoclonal antibody against CD52, which is shown to be effective in the treatment of relapsing-remitting multiple sclerosis (RRMS). Here, we present a rare case of TS developing in a 39-year-old female with ALZ-induced GD, managed with antithyroid medication followed by thyroidectomy. There is some evidence that ALZ-induced GD may behave less aggressively than conventional GD. However, physicians should be aware that severe thyrotoxicosis and thyroid storm can happen, which requires prompt recognition and aggressive therapy. |
format | Online Article Text |
id | pubmed-9138563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-91385632022-05-31 Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report AlShehri, Sara Alajmi, Sarah Ekhzaimy, Aishah Aldawas, Sadeem Alalwan, Maryam Cureus Endocrinology/Diabetes/Metabolism Thyroid storm (TS) is a rare and life-threatening medical emergency, most commonly caused by Graves’ disease (GD). GD can be induced by immune reconstitution therapy (IRT) such as alemtuzumab (ALZ), a humanized monoclonal antibody against CD52, which is shown to be effective in the treatment of relapsing-remitting multiple sclerosis (RRMS). Here, we present a rare case of TS developing in a 39-year-old female with ALZ-induced GD, managed with antithyroid medication followed by thyroidectomy. There is some evidence that ALZ-induced GD may behave less aggressively than conventional GD. However, physicians should be aware that severe thyrotoxicosis and thyroid storm can happen, which requires prompt recognition and aggressive therapy. Cureus 2022-04-28 /pmc/articles/PMC9138563/ /pubmed/35651398 http://dx.doi.org/10.7759/cureus.24570 Text en Copyright © 2022, AlShehri et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism AlShehri, Sara Alajmi, Sarah Ekhzaimy, Aishah Aldawas, Sadeem Alalwan, Maryam Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report |
title | Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report |
title_full | Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report |
title_fullStr | Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report |
title_full_unstemmed | Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report |
title_short | Thyroid Storm in a Patient With Alemtuzumab-Induced Graves’ Disease: A Case Report |
title_sort | thyroid storm in a patient with alemtuzumab-induced graves’ disease: a case report |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138563/ https://www.ncbi.nlm.nih.gov/pubmed/35651398 http://dx.doi.org/10.7759/cureus.24570 |
work_keys_str_mv | AT alshehrisara thyroidstorminapatientwithalemtuzumabinducedgravesdiseaseacasereport AT alajmisarah thyroidstorminapatientwithalemtuzumabinducedgravesdiseaseacasereport AT ekhzaimyaishah thyroidstorminapatientwithalemtuzumabinducedgravesdiseaseacasereport AT aldawassadeem thyroidstorminapatientwithalemtuzumabinducedgravesdiseaseacasereport AT alalwanmaryam thyroidstorminapatientwithalemtuzumabinducedgravesdiseaseacasereport |